AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westphal, S.
Right arrow Articles by Luley, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westphal, S.
Right arrow Articles by Luley, C.
Agricola
Right arrow Articles by Westphal, S.
Right arrow Articles by Luley, C.
American Journal of Clinical Nutrition, Vol. 71, No. 4, 914-920, April 2000
© 2000 American Society for Clinical Nutrition


Original Research Communications

Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids1,2

Sabine Westphal, Matthias Orth, Andreas Ambrosch, Karen Osmundsen and Claus Luley

1 From the Institute of Clinical Chemistry, Magdeburg University Hospital, Magdeburg, Germany and Pronova Biocare, Lysaker, Norway.

Background: n-3 Fatty acids lower plasma triacylglycerols not only in the fasting state but also in the postprandial state. However, it is not known whether chylomicrons, chylomicron remnants, and VLDLs are all affected equally or whether some lipoprotein species are lowered preferentially.

Objective: Lipoproteins, including large and small chylomicron remnants, were determined specifically with the aid of a newly developed method involving a combination of size-exclusion chromatography and fluorometric determination of retinyl palmitate, which served as a marker for exogenous fat.

Design: Twelve hypertriacylglycerolemic men were treated for 6 wk with 4 capsules containing 85% fish-oil concentrate/d; each capsule contained 850 mg n-3 fatty acid ethyl esters (49.1% eicosapentaenoic acid by wt and 32.2% docosahexaenoic acid by wt). Oral-fat-tolerance tests were performed before and after the treatment. Blood samples were drawn in the fasting state and until 8 h postprandially.

Results: Treatment with n-3 fatty acids reduced the fasting VLDL-triacylglycerol concentration by 44% (P < 0.05) and postprandial chylomicrons and VLDLs at 4, 6, and 8 h (P < 0.05) by 49–64% and 36–43%, respectively. Chylomicron remnants were reduced only in the late postprandial phase: large chylomicron remnants by 19% at 6 h and by 43% at 8 h (P < 0.05) and small chylomicron remnants by 31% at 8 h (P < 0.05).

Conclusion: n-3 Fatty acids effectively lower chylomicrons and VLDLs, but their effect on chylomicron remnants was observed only in the late postprandial phase.

Key Words: n-3 Fatty acids • fish oil • hypertriacylglycerolemia • postprandial effects • lipoproteins • chylomicron remnants • chylomicrons • VLDL • men




This article has been cited by other articles:


Home page
J. Nutr.Home page
H. E. C. Hanwell, C. D. Kay, J. W. Lampe, B. J. Holub, and A. M. Duncan
Acute Fish Oil and Soy Isoflavone Supplementation Increase Postprandial Serum (n-3) Polyunsaturated Fatty Acids and Isoflavones but Do Not Affect Triacylglycerols or Biomarkers of Oxidative Stress in Overweight and Obese Hypertriglyceridemic Men
J. Nutr., June 1, 2009; 139(6): 1128 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
N. Collins, A. P. Tighe, S. A. Brunton, and P. M. Kris-Etherton
Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective
J. Am. Coll. Nutr., December 1, 2008; 27(6): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. A Jacobson
Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1981S - 1990S.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. M Malinowski and K. Metka
Elevation of Low-Density Lipoprotein Cholesterol Concentration with Over-the-Counter Fish Oil Supplementation
Ann. Pharmacother., July 1, 2007; 41(7): 1296 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Vanschoonbeek, M. A. H. Feijge, W. H. M. Saris, M. P. M. de Maat, and J. W. M. Heemskerk
Plasma Triacylglycerol and Coagulation Factor Concentrations Predict the Anticoagulant Effect of Dietary Fish Oil in Overweight Subjects
J. Nutr., January 1, 2007; 137(1): 7 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. F. Larsen, A. K. Olsen, A. K. Hansen, K. Bukhave, and P. Marckmann
Feeding Minipigs Fish Oil for Four Weeks Lowers Postprandial Triacylglycerolemia
J. Nutr., July 1, 2003; 133(7): 2273 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. C Chan, G. F Watts, T. A Mori, P H. R Barrett, T. G Redgrave, and L. J Beilin
Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity
Am. J. Clinical Nutrition, February 1, 2003; 77(2): 300 - 307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The American Society for Nutrition